Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tamori, Y.
Right arrow Articles by Kasuga, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tamori, Y.
Right arrow Articles by Kasuga, M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 51:2045-2055, 2002
© 2002 by the American Diabetes Association, Inc.

Role of Peroxisome Proliferator-Activated Receptor-{gamma} in Maintenance of the Characteristics of Mature 3T3-L1 Adipocytes

Yoshikazu Tamori, Jiro Masugi, Naonobu Nishino, and Masato Kasuga

From the Division of Diabetes, Digestive, and Kidney Diseases, Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan

Peroxisome proliferator–activated receptor (PPAR)-{gamma} plays an important role in adipogenesis. However, the functions of PPAR-{gamma} in differentiated adipocytes have remained unclear. The role of PPAR-{gamma} in mature 3T3-L1 adipocytes was therefore investigated by overexpression of a dominant negative mutant of this protein (PPAR-{gamma}-{Delta}C) that lacks the 16 COOH-terminal amino acids and that has been shown to prevent the thiazolidinedione-induced differentiation of 3T3-L1 cells into adipocytes. Overexpression of PPAR-{gamma}-{Delta}C in mature 3T3-L1 adipocytes by adenovirus gene transfer resulted in a decrease in both cell size and intracellular triglyceride content, an increase in the extent of lipolysis, and a reduction in the rate of free fatty acid uptake. Furthermore, overexpression of this mutant reduced the abundance of mRNAs for several key enzymes that contribute to triglyceride and free fatty acid metabolism as well as the amounts of GLUT4, insulin receptor, insulin receptor substrate (IRS), and C/EBP{alpha} mRNAs. It also reduced both the concentration of IRS2 and the insulin-stimulated glucose uptake. These results suggest that PPAR-{gamma} plays an important role in mature 3T3-L1 adipocytes at least in part by maintaining the expression of genes that confer the characteristics of mature adipocytes.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J ANIM SCIHome page
N. K. Singh, H. S. Chae, I. H. Hwang, Y. M. Yoo, C. N. Ahn, S. H. Lee, H. J. Lee, H. J. Park, and H. Y. Chung
Transdifferentiation of porcine satellite cells to adipoblasts with ciglitizone
J Anim Sci, May 1, 2007; 85(5): 1126 - 1135.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Rodrigue-Way, A. Demers, H. Ong, and A. Tremblay
A Growth Hormone-Releasing Peptide Promotes Mitochondrial Biogenesis and a Fat Burning-Like Phenotype through Scavenger Receptor CD36 in White Adipocytes
Endocrinology, March 1, 2007; 148(3): 1009 - 1018.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. E. Feldon, C. W. O'Loughlin, D. M. Ray, S. Landskroner-Eiger, K. E. Seweryniak, and R. P. Phipps
Activated Human T Lymphocytes Express Cyclooxygenase-2 and Produce Proadipogenic Prostaglandins that Drive Human Orbital Fibroblast Differentiation to Adipocytes
Am. J. Pathol., October 1, 2006; 169(4): 1183 - 1193.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Chihara, H. Rakugi, K. Ishikawa, M. Ikushima, Y. Maekawa, J. Ohta, I. Kida, and T. Ogihara
Klotho Protein Promotes Adipocyte Differentiation
Endocrinology, August 1, 2006; 147(8): 3835 - 3842.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. Desvergne, L. Michalik, and W. Wahli
Transcriptional Regulation of Metabolism
Physiol Rev, April 1, 2006; 86(2): 465 - 514.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. B. Goldfine, S. Crunkhorn, M. Costello, H. Gami, E. J. Landaker, M. Niinobe, K. Yoshikawa, D. Lo, A. Warren, J. Jimenez-Chillaron, et al.
Necdin and E2F4 Are Modulated by Rosiglitazone Therapy in Diabetic Human Adipose and Muscle Tissue
Diabetes, March 1, 2006; 55(3): 640 - 650.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Y. Yin, H. Yuan, C. Wang, N. Pattabiraman, M. Rao, R. G. Pestell, and R. I. Glazer
3-Phosphoinositide-Dependent Protein Kinase-1 Activates the Peroxisome Proliferator-Activated Receptor-{gamma} and Promotes Adipocyte Differentiation
Mol. Endocrinol., February 1, 2006; 20(2): 268 - 278.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. Gonzalez-Yanes, A. Serrano, F. J. Bermudez-Silva, M. Hernandez-Dominguez, M. A. Paez-Ochoa, F. R. de Fonseca, and V. Sanchez-Margalet
Oleylethanolamide impairs glucose tolerance and inhibits insulin-stimulated glucose uptake in rat adipocytes through p38 and JNK MAPK pathways
Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E923 - E929.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Fukuen, M. Iwaki, A. Yasui, M. Makishima, M. Matsuda, and I. Shimomura
Sulfonylurea Agents Exhibit Peroxisome Proliferator-activated Receptor {gamma} Agonistic Activity
J. Biol. Chem., June 24, 2005; 280(25): 23653 - 23659.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. R. Jones, C. Barrick, K.-A. Kim, J. Lindner, B. Blondeau, Y. Fujimoto, M. Shiota, R. A. Kesterson, B. B. Kahn, and M. A. Magnuson
Deletion of PPAR{gamma} in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance
PNAS, April 26, 2005; 102(17): 6207 - 6212.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. Knouff and J. Auwerx
Peroxisome Proliferator-Activated Receptor-{gamma} Calls for Activation in Moderation: Lessons from Genetics and Pharmacology
Endocr. Rev., December 1, 2004; 25(6): 899 - 918.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C.-K. Hyun, I.-Y. Kim, and S. C. Frost
Soluble Fibroin Enhances Insulin Sensitivity and Glucose Metabolism in 3T3-L1 Adipocytes
J. Nutr., December 1, 2004; 134(12): 3257 - 3263.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Schupp, J. Janke, R. Clasen, T. Unger, and U. Kintscher
Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator-Activated Receptor-{gamma} Activity
Circulation, May 4, 2004; 109(17): 2054 - 2057.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Nagai, C. Shimizu, M. Umetsu, S. Taniguchi, M. Endo, H. Miyoshi, N. Yoshioka, M. Kubo, and T. Koike
Identification of a Functional Peroxisome Proliferator-Activated Receptor Responsive Element within the Murine Perilipin Gene
Endocrinology, May 1, 2004; 145(5): 2346 - 2356.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Orio Jr., G. Matarese, S. Di Biase, S. Palomba, D. Labella, V. Sanna, S. Savastano, F. Zullo, A. Colao, and G. Lombardi
Exon 6 and 2 Peroxisome Proliferator-Activated Receptor-{gamma} Polymorphisms in Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5887 - 5892.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Tiraby, G. Tavernier, C. Lefort, D. Larrouy, F. Bouillaud, D. Ricquier, and D. Langin
Acquirement of Brown Fat Cell Features by Human White Adipocytes
J. Biol. Chem., August 29, 2003; 278(35): 33370 - 33376.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.